“…There was some heterogeneity in the clinical characteristics of the study populations. In summary, twenty studies recruited non-insulin-dependent T2DM subjects with the following characteristics [ 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 ]: in nine studies, the subjects received only oral antidiabetic drugs [ 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 ]; in three studies, the subjects were newly T2DM-diagnosed subjects [ 50 , 51 , 52 ]; in three studies, the T2DM subjects had a chronic renal disease [ 53 , 54 , 55 ]; in two studies, the T2DM subjects reported levels of HbA1c higher than 7% [ 56 , 57 ]; in two studies, the T2DM subjects had normal blood pressure [ 58 , 59 ]; in two studies, the T2DM subjects were women without cardiovascular disease [ 60 , 61 ]; in one study, the subjects were T2DM postmenopausal women [ 62 ]; in one study, the T2DM subjects also had hyperlipidemia [ 63 ]; and in one study, T2DM subjects also had a metabolic syndrome [ 64...…”